See also this year's filing and all EDGAR filings for this company.
PDF Report 0000315545_2012_Provectus_Biopharmaceuticals_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000315545, Provectus Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 7,705,773 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 5,597,068 |
| 2 | PropertyPlantAndEquipmentNet | 20,111 |
| 3 | remainder_Assets | 27,000 |
| 4 | LiabilitiesCurrent | 262,724 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 3,067,488 |
| 7 | CostOfGoodsAndServicesSold | 15,216 |
| 8 | SellingGeneralAndAdministrativeExpense | 57,524,849 |
| 9 | ResearchAndDevelopmentExpense | 38,093,394 |
| 10 | remainder_Expenses | 14,216,381 |
| 11 | remainder_Revenues | 39,757 |
| 12 | remainder_NetIncome | 4,025,361 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 13,349,952 |
| 1 | Liabilities | 3,330,212 |
| 2 | Expenses | 109,849,840 |
| 3 | Revenues | 39,757 |
| 4 | StockholdersEquity | 10,019,740 |
| 5 | NetIncome | -105,784,722 |
| 6 | ComprehensiveNetIncome | -105,784,722 |
| 7 | BaseVar | 65,297,561 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -10.1 |
| 9 | EconomicCapitalRatio | 0.000426 |